A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.

  • reluctantpornaccount@reddthat.com
    link
    fedilink
    arrow-up
    15
    arrow-down
    10
    ·
    1 year ago

    The track record for weight loss drugs is not good. Even “approved” ones. We had a lot of teenagers on amphetamines to make them lose weight.

    The podcast Maintenance Phase has at least one episode on them and their history.

    • SeaJ@lemm.ee
      link
      fedilink
      arrow-up
      10
      ·
      1 year ago

      The results for this and Wegovy are pretty promising. That said, the long term effects are unknown since they are so new. But the long term effects of having a BMI over 30 are pretty terrible and well known. These are nothing like amphetamines.

      • ChexMax@lemmy.world
        link
        fedilink
        arrow-up
        1
        arrow-down
        2
        ·
        1 year ago

        The results are that they were only tested on perfectly healthy people which is not indicative of their success in the general population, and the results were also that most people gained the weight back immediately upon stopping the drug.

        The side effects were not too bad for people getting the drug for free, but at 1k a month, those side effects cause much higher drop out rates as well.

        Still way more promising than anything else available, but not that promising overall.

    • books@lemmy.world
      link
      fedilink
      arrow-up
      7
      arrow-down
      1
      ·
      1 year ago

      Eh these people are either gonna be taking bp/cholesterol/diabetes medication or this. Seems like it has the potential to be a wash?